
Interleukin-6, Tumor Necrosis Factor-alpha, Antibodies, Monoclonal, HLA-DR Antigens, Prognosis, Receptors, Interleukin-6, Arthritis, Juvenile, Infliximab, Receptors, Tumor Necrosis Factor, Etanercept, Rheumatoid Factor, Antibodies, Antinuclear, Immunoglobulin G, HLA-DR4 Antigen, Humans, HLA-DR Serological Subtypes
Interleukin-6, Tumor Necrosis Factor-alpha, Antibodies, Monoclonal, HLA-DR Antigens, Prognosis, Receptors, Interleukin-6, Arthritis, Juvenile, Infliximab, Receptors, Tumor Necrosis Factor, Etanercept, Rheumatoid Factor, Antibodies, Antinuclear, Immunoglobulin G, HLA-DR4 Antigen, Humans, HLA-DR Serological Subtypes
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
